TGFB2 and cholangiocarcinoma: These data and our findings demonstrating TGF-β2 expression in diseased liver cells, total liver and HCC lysates and its possibly special role in biliary diseases suggest studying the role of TGF-β2 in hepatocyte-derived cholangiocarcinomas in the future.